Jean-Pierre Sommadossi, Atea Pharmaceuticals CEO (Atea)
Pharmasset co-founder jumps into Covid-19 fight, with a new company and $215 million to get there
For 7 years, Atea Pharmaceuticals hummed along, another biotech in a city full of them, filing patents, quietly picking up a few small funding rounds …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.